Replies to post #13215 on Moderna Inc (MRNA)

[axelvento]

news imminent -$$$$$

On 13-16 February, 2024

https://resvinet.org/conferences/rsvvw24/

Statement on RSVVW Abstract on mRNA-1345


At an upcoming presentation at the RSVVW’24 conference, Moderna will share follow-up data from its ongoing ConquerRSV Phase 3 study of its investigational RSV vaccine candidate, mRNA-1345.